On March 20, 2026, Accord BioPharma, Inc. (“Accord”), Intas Pharmaceuticals Ltd. (“Intas”), and Bio-Thera Solutions, Ltd. (“Bio-Thera,” collectively ...

Janssen Biotech, Inc. (Janssen), one of the Janssen pharmaceutical companies of Johnson & Johnson announced today an exclusive, worldwide license agreement with Alligator Bioscience AB for ADC-1013, ...

Natco Pharma was hit with a patent infringement lawsuit on Oct. 15 in New Jersey District Court over its attempt to market a generic version of the cancer drug Balversa. The action, brought by ...

Xoma argued Janssen breached the contract Xoma had with the third-party pharmaceutical company, as well as the contract the company and Janssen had, by failing to obtain a commercial license from Xoma ...

FRANKFURT, Oct 23 (Reuters) - German biotech company Morphosys raised its earnings forecast for 2014, citing a milestone payment from Janssen Biotech as well as a partial shift of development costs to ...

Get all latest & breaking news on Janssen Pharmaceuticals. Watch videos, top stories and articles on Janssen Pharmaceuticals ...